NCI and NIOH to purchase additional MammoView line of surgical endoscopy instruments

Oct 24 2009

Solos Endoscopy, Inc. (Pink Sheets: SNDY) is pleased to announce that the Company has received additional purchase orders for its MammoView(TM) line of surgical endoscopy instruments from the National Cancer Institute (NCI), as well as the U.S. National Institute of Health (NIOH), which is part of the U.S. Department of Health and Human Services. Solos Endoscopy's MammoView(TM) line of endoscopy surgical instruments has received positive reviews from various surgeons who have been regularly using the instruments during their endoscopic procedures.

NCI is 1 of 27 Institutes and Centers that comprise the U.S. National Institutes of Health. Located in Bethesda, Maryland, NIOH is the primary Federal agency for conducting and supporting medical research. Solos Endoscopy's MammoView(TM) system employs advanced micro endoscopes and optical technology to give physicians sharp, clear images of the milk ducts where the majority of breast cancers arise.

"The cytology retrieval kit which contains miniature brushes and a mini aspirator is, in my opinion, the best method for retrieving cell samples from the lining of the mammary duct," stated David N. Danforth Jr., M.S., M.D., Surgery Branch Senior Investigator from the National Institute of Health.

"We are very pleased to continue supplying our MammoView(TM) surgical endoscopy instruments to the top cancer care and research organizations in the country. We believe, as the body of research expands, more and more surgeons will utilize our system, which will enable them to detect possible cancerous cells in its early stage and begin treatments immediately on their patients," stated Bob Segersten, President of Solos Endoscopy, Inc.

Solos Endoscopy recently announced that the Company has taken the initial steps to get the CE Marking for its FDA approved MammoView(TM) line of surgical instruments. This will allow the MammoView(TM) line to be sold throughout the European Economic Union (EEU), which represents 30% or $94 Billion of the worldwide demand for medical instruments.